| Literature DB >> 36066492 |
Richard T Piszczatowski1, Emily Schwenger1, Sriram Sundaravel1, Catarina M Stein2, Yang Liu2, Pamela Stanley1,3, Amit Verma4,5,3,6,7, Deyou Zheng2,8,9, Ronald D Seidel10, Steven C Almo10,3, Robert A Townley2,10,6, Hannes E Bülow2,8,3, Ulrich Steidl1,5,3,7,11.
Abstract
Cell surfaces display a wide array of molecules that confer identity. While flow cytometry and cluster of differentiation (CD) markers have revolutionized cell characterization and purification, functionally heterogeneous cellular subtypes remain unresolvable by the CD marker system alone. Using hematopoietic lineages as a paradigm, we leverage the extraordinary molecular diversity of heparan sulfate (HS) glycans to establish cellular "glycotypes" by utilizing a panel of anti-HS single-chain variable fragment antibodies (scFvs). Prospective sorting with anti-HS scFvs identifies functionally distinct glycotypes within heterogeneous pools of mouse and human hematopoietic progenitor cells and enables further stratification of immunophenotypically pure megakaryocyte-erythrocyte progenitors. This stratification correlates with expression of a heptad of HS-related genes that is reflective of the HS epitope recognized by specific anti-HS scFvs. While we show that HS glycotyping provides an orthogonal set of tools for resolution of hematopoietic lineages, we anticipate broad utility of this approach in defining and isolating novel, viable cell types across diverse tissues and species.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36066492 PMCID: PMC9455685 DOI: 10.1084/jem.20212552
Source DB: PubMed Journal: J Exp Med ISSN: 0022-1007 Impact factor: 17.579